MedTrace Logo

Analgesia After Cesarean Section

NCT01360060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 503

Last updated 2011-05-25

No results posted yet for this study

Summary

Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of magnesium in parturients undergoing Cesarean section.

Conditions

Interventions

DRUG

Magnesium Sulphate

Magnesium sulphate was infused for the management of preeclampsia at perioperative period.

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01360060 on ClinicalTrials.gov